Svenskt biotechbolag nära genombrott i behandling mot covid-19 – söker investerare

Researchers at the biotech company Amniotics in Lund has developed a lung specific stem cell for treatment of covid-19. The market for treating lung- and airway diseases is valued at 47 billion Euro.

– At present, we are working day and night to finish our process validation. We are in close contact with the Swedish Medical Products Agency (Läkemedelsverket) to initiate a clinical trial and we hope to soon be able to send an application, says Kåre Engkilde, CEO at Amniotics.

https://www.di.se/brandstudio/amniotics/svenskt-biotechbolag-nara-genombrott-i-behandling-mot-covid-19-soker-investerare/

In the News
16 April, 2020
WP to LinkedIn Auto Publish Powered By : XYZScripts.com